Aptevo Therapeutics Inc.
APVO
$1.85
-$0.04-1.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.41M | -26.26M | -25.97M | -26.47M | -24.03M |
| Total Depreciation and Amortization | 197.00K | 214.00K | 240.00K | 230.00K | 265.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.82M | 1.61M | 1.73M | 1.67M | 1.74M |
| Change in Net Operating Assets | -956.00K | -2.55M | -1.60M | -1.54M | -2.63M |
| Cash from Operations | -25.34M | -26.98M | -25.59M | -26.12M | -24.65M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25.73M | 39.37M | 38.50M | 38.95M | 25.52M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00K | -1.00K | -- | 472.00K | 472.00K |
| Cash from Financing | 25.73M | 39.37M | 38.50M | 39.42M | 25.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 387.00K | 12.39M | 12.91M | 13.31M | 1.34M |